Title : Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways.

Pub. Date : 2022 Apr

PMID : 34890285






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic Inhibitory Effects of 5-Aza-2"-Deoxycytidine and Cisplatin on Urothelial Carcinoma Growth via Suppressing TGFBI-MAPK Signaling Pathways. Cisplatin transforming growth factor beta induced Homo sapiens
2 The results showed that several key regulatory genes, such as interleukin 24(IL24), fibroblast growth factor 1(FGF1), and transforming growth factor beta-induced (TGFBI), were identified and may play critical roles in the synergy of DAC and CDDP in UC. Cisplatin transforming growth factor beta induced Homo sapiens
3 The results showed that several key regulatory genes, such as interleukin 24(IL24), fibroblast growth factor 1(FGF1), and transforming growth factor beta-induced (TGFBI), were identified and may play critical roles in the synergy of DAC and CDDP in UC. Cisplatin transforming growth factor beta induced Homo sapiens
4 Our results suggested that TGF-beta1 stimulates the phosphorylation levels of ERK1/2 and p38 via increasing TGFBI expression, TGFBI-MAPK signaling pathway plays an important role in the synergy of DAC and CDDP against UC. Cisplatin transforming growth factor beta induced Homo sapiens
5 Our results suggested that TGF-beta1 stimulates the phosphorylation levels of ERK1/2 and p38 via increasing TGFBI expression, TGFBI-MAPK signaling pathway plays an important role in the synergy of DAC and CDDP against UC. Cisplatin transforming growth factor beta induced Homo sapiens
6 Therefore, we revealed the synergistic mechanism of DAC and CDDP in UC, several key regulatory genes play critical roles in the synergy of combined treatment, and TGFBI-MAPK signaling pathway may be an important potential target of these two agents. Cisplatin transforming growth factor beta induced Homo sapiens